Dissemination of novel antimicrobial resistance mechanisms through the insertion sequence mediated spread of metabolic genes

Frontiers in Microbiology

Volumn 7, Issue JUN, 2016, Pages

  Furi, Leonardo ^a,b   Haigh, Richard ^a   Al Jabri, Zaaima J ^a   Morrissey, Ian ^c   Ou, Hong Yu ^d   León Sampedro, Ricardo ^e,f   Martinez, Jose L ^g,h   Coque, Teresa M ^e,f,h   Oggioni, Marco R ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF SIENA   (Italy)

^c International Health Management Associates Europe Sàrl   (Switzerland)

^d Shanghai Jiao Tong University   (China)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^h CSIC   (Spain)

Author keywords

Antimicrobial drug resistance; FabI; Insertion sequence; IS1182 family; IS5 family; Metabolism; Resistance risk; Transposon

Indexed keywords

PSEUDOMONIC ACID; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BIOINFORMATICS; CONTROLLED STUDY; GENE INSERTION SEQUENCE; GENE SEQUENCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENETIC TREE; PROTEIN SECONDARY STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 84980332305     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01008     Document Type: Article

References (57)

1. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., et al. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402. doi: 10.1093/nar/25.17.3389.
2. Andersson, D. I. (2006). The biological cost of mutational antibiotic resistance: any practical conclusions? Curr. Opin. Microbiol. 9, 461-465. doi: 10.1016/j.mib.2006.07.002.
3. Archer, G. L., Niemeyer, D. M., Thanassi, J. A., and Pucci, M. J. (1994). Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrob. Agents Chemother. 38, 447-454. doi: 10.1128/AAC.38.3.447.
4. Archer, G. L., Thanassi, J. A., Niemeyer, D. M., and Pucci, M. J. (1996). Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 40, 924-929.
5. Balemans, W., Lounis, N., Gilissen, R., Guillemont, J., Simmen, K., Andries, K., et al. (2010). Essentiality of FASII pathway for Staphylococcus aureus. Nature 463, E3. discussion: E4. doi: 10.1038/nature08667.
6. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., et al. (1994). inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-230.
7. Barth, P. T., Datta, N., Hedges, R. W., and Grinter, N. J. (1976). Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistances from R483 to other replicons. J. Bacteriol. 125, 800-810.
8. Bosi, E., Donati, B., Galardini, M., Brunetti, S., Sagot, M. F., Lio, P., et al. (2015). MeDuSa: a multi-draft based scaffolder. Bioinformatics 31, 2443-2451. doi: 10.1093/bioinformatics/btv171.
9. Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., and Poyart, C. (2009). Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 458, 83-86. doi: 10.1038/nature07772.
10. Bush, K. (2013). Proliferation and significance of clinically relevant beta-lactamases. Ann. N.Y. Acad. Sci. 1277, 84-90. doi: 10.1111/nyas.12023.
11. Cavanagh, J. P., Hjerde, E., Holden, M. T., Kahlke, T., Klingenberg, C., Flaegstad, T., et al. (2014). Whole-genome sequencing reveals clonal expansion of multiresistant Staphylococcus haemolyticus in European hospitals. J. Antimicrob. Chemother. 69, 2920-2927. doi: 10.1093/jac/dku271.
12. Ciusa, M. L., Furi, L., Knight, D., Decorosi, F., Fondi, M., Raggi, C., et al. (2012). A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus. Int. J. Antimicrob. Agents 40, 210-220. doi: 10.1016/j.ijantimicag.2012.04.021.
13. Coelho, J. R., Carrico, J. A., Knight, D., Martinez, J. L., Morrissey, I., Oggioni, M. R., et al. (2013). The use of machine learning methodologies to analyse antibiotic and biocide susceptibility in Staphylococcus aureus. PLoS ONE 8:e55582. doi: 10.1371/journal.pone.0055582.
14. Dale, G. E., Broger, C., Hartman, P. G., Langen, H., Page, M. G., Then, R. L., et al. (1995). Characterization of the gene for the chromosomal dihydrofolate reductase (DHFR) of Staphylococcus epidermidis ATCC 14990: the origin of the trimethoprim-resistant S1 DHFR from Staphylococcus aureus? J. Bacteriol. 177, 2965-2970.
15. Deeny, S. R., Worby, C. J., Tosas Auguet, O., Cooper, B. S., Edgeworth, J., Cookson, B., et al. (2015). Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA. J. Antimicrob. Chemother. 70, 3366-3378. doi: 10.1093/jac/dkv249.
16. Escaich, S., Prouvensier, L., Saccomani, M., Durant, L., Oxoby, M., Gerusz, V., et al. (2011). The MUT056399 inhibitor of FabI is a new antistaphylococcal compound. Antimicrob. Agents Chemother. 55, 4692-4697. doi: 10.1128/AAC.01248-10.
17. Fagerlund, A., Granum, P. E., and Havarstein, L. S. (2014). Staphylococcus aureus competence genes: mapping of the SigH, ComK1 and ComK2 regulons by transcriptome sequencing. Mol. Microbiol. 94, 557-579. doi: 10.1111/mmi.12767.
18. Furi, L., Ciusa, M. L., Knight, D., Di Lorenzo, V., Tocci, N., Cirasola, D., et al. (2013). Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 57, 3488-3497. doi: 10.1128/AAC.00498-13.
19. Gilbart, J., Perry, C. R., and Slocombe, B. (1993). High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob. Agents Chemother. 37, 32-38. doi: 10.1128/AAC.37.1.32.
20. Grandgirard, D., Furi, L., Ciusa, M. L., Baldassarri, L., Knight, D. R., Morrissey, I., et al. (2015). Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression. BMC Genomics 16:345 doi: 10.1186/s12864-015-1544-y.
21. Heath, R. J., Rubin, J. R., Holland, D. R., Zhang, E., Snow, M. E., and Rock, C. O. (1999). Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J. Biol. Chem. 274, 11110-11114. doi: 10.1074/jbc.274.16.11110.
22. Heath, R. J., White, S. W., and Rock, C. O. (2001). Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40, 467-497. doi: 10.1016/S0163-7827(01)00012-1.
23. Hedges, R. W., and Jacob, A. E. (1974). Transposition of ampicillin resistance from RP4 to other replicons. Mol. Gen. Genet. 132, 31-40. doi: 10.1007/BF00268228.
24. Hetem, D. J., and Bonten, M. J. (2013). Clinical relevance of mupirocin resistance in Staphylococcus aureus. J. Hosp. Infect. 85, 249-256. doi: 10.1016/j.jhin.2013.09.006.
25. Hijazi, K., Mukhopadhya, I., Abbott, F., Milne, K., Al-Jabri, Z. J., Oggioni, M. R., et al. (2016). Susceptibility to chlorhexidine amongst multidrug-resistant clinical isolates of Staphylococcus Epidermidis from bloodstream infections. Int. J. Antimicrob. Agents. doi: 10.1016/j.ijantimicag.2016.04.015. [Epub ahead of print].
26. Isola, D., Pardini, M., Varaine, F., Niemann, S., Rusch-Gerdes, S., Fattorini, L., et al. (2005). A pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. J. Microbiol. Methods 62, 113-120. doi: 10.1016/j.mimet.2005.02.004.
27. Ji, Y., Yin, D., Fox, B., Holmes, D. J., Payne, D., and Rosenberg, M. (2004). Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus. FEMS Microbiol. Lett. 231, 177-184. doi: 10.1016/S0378-1097(03)00931-5.
28. Kaplan, N., Albert, M., Awrey, D., Bardouniotis, E., Berman, J., Clarke, T., et al. (2012). Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor. Antimicrob. Agents Chemother. 56, 5865-5874. doi: 10.1128/AAC.01411-12.
29. Lanza, V. F., Tedim, A. P., Martinez, J. L., Baquero, F., and Coque, T. M. (2015). The plasmidome of firmicutes: impact on the emergence and the spread of resistance to antimicrobials. Microbiol. Spectr. 3:PLAS-0039-2014. doi: 10.1128/microbiolspec.plas-0039-2014.
30. Larsen, M. V., Cosentino, S., Rasmussen, S., Friis, C., Hasman, H., Marvig, R. L., et al. (2012). Multilocus sequence typing of total-genome-sequenced bacteria. J. Clin. Microbiol. 50, 1355-1361. doi: 10.1128/JCM.06094-11.
31. Leelaporn, A., Firth, N., Paulsen, I. T., and Skurray, R. A. (1996). IS257-mediated cointegration in the evolution of a family of staphylococcal trimethoprim resistance plasmids. J. Bacteriol. 178, 6070-6073.
32. León-Sampedro, R., Novais, C., Peixe, L., Baquero, F., and Coque, T. M. (2016). Diversity and evolution of the Tn5801-tet(M)-like integrative and conjugative elements among Enterococcus, Streptococcus, and Staphylococcus. Antimicrob. Agents Chemother. 60, 1736-1746. doi: 10.1128/AAC.01864-15.
33. Li, H. (2014). Toward better understanding of artifacts in variant calling from high-coverage samples. Bioinformatics 30, 2843-2851. doi: 10.1093/bioinformatics/btu356.
34. Lu, H., and Tonge, P. J. (2008). Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway. Acc. Chem. Res. 41, 11-20. doi: 10.1021/ar700156e.
35. Maillard, J. Y., Bloomfield, S., Coelho, J. R., Collier, P., Cookson, B., Fanning, S., et al. (2013). Does microbicide use in consumer products promote antimicrobial resistance? a critical review and recommendations for a cohesive approach to risk assessment. Microb. Drug Resist. 19, 344-354. doi: 10.1089/mdr.2013.0039.
36. Martinez, J. L., Coque, T. M., and Baquero, F. (2015). What is a resistance gene? Ranking risk in resistomes. Nat. Rev. Microbiol. 13, 116-123. doi: 10.1038/nrmicro3399.
37. Morrissey, I., Oggioni, M. R., Knight, D., Curiao, T., Coque, T., Kalkanci, A., et al. (2014). Evaluation of epidemiological cut-offvalues indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms. PLoS ONE 9:e86669. doi: 10.1371/journal.pone.0086669.
38. Needham, C., Noble, W. C., and Dyke, K. G. (1995). The staphylococcal insertion sequence IS257 is active. Plasmid 34, 198-205. doi: 10.1006/plas.1995.0005.
39. Needham, C., Rahman, M., Dyke, K. G., and Noble, W. C. (1994). An investigation of plasmids from Staphylococcus aureus that mediate resistance to mupirocin and tetracycline. Microbiology 140 (Pt 10), 2577-2583. doi: 10.1099/00221287-140-10-2577.
40. Oggioni, M. R., Ciusa, M. L., Furi, L., Baldassarri, L., Orefici, G., Cirasola, D., et al. (2012). Lack of evidence for reduced fitness of clinical Staphylococcus aureus isolates with reduced susceptibility to triclosan. Antimicrob. Agents Chemother. 56, 6068-6069. doi: 10.1128/AAC.01055-12.
41. Oggioni, M. R., Coelho, J. R., Furi, L., Knight, D. R., Viti, C., Orefici, G., et al. (2015). Significant differences characterise the correlation coefficients between biocide and antibiotic susceptibility profiles in Staphylococcus aureus. Curr. Pharm. Des. 21, 2054-2057. doi: 10.2174/1381612821666150310103238.
42. Oggioni, M. R., Furi, L., Coelho, J. R., Maillard, J. Y., and Martinez, J. L. (2013). Recent advances in the potential interconnection between antimicrobial resistance to biocides and antibiotics. Expert Rev. Anti Infect. Ther. 11, 363-366. doi: 10.1586/eri.13.16.
43. Oggioni, M. R., Meacci, F., Carattoli, A., Ciervo, A., Orru, G., Cassone, A., et al. (2002). Protocol for real-time PCR identification of anthrax spores from nasal swabs after broth enrichment. J. Clin. Microbiol. 40, 3956-3963. doi: 10.1128/JCM.40.11.3956-3963.2002.
44. Park, H. S., Yoon, Y. M., Jung, S. J., Kim, C. M., Kim, J. M., and Kwak, J. H. (2007). Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. J. Antimicrob. Chemother. 60, 568-574. doi: 10.1093/jac/dkm236.
45. Payne, D. J., Warren, P. V., Holmes, D. J., Ji, Y., and Lonsdale, J. T. (2001). Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery. Drug Discov. Today 6, 537-544. doi: 10.1016/S1359-6446(01)01774-3.
46. Reuter, J. S., and Mathews, D. H. (2010). RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinformatics 11:129. doi: 10.1186/1471-2105-11-129.
47. Roach, D. J., Burton, J. N., Lee, C., Stackhouse, B., Butler-Wu, S. M., Cookson, B. T., et al. (2015). A year of infection in the intensive care unit: prospective whole genome sequencing of bacterial clinical isolates reveals cryptic transmissions and novel microbiota. PLoS Genet. 11:e1005413. doi: 10.1371/journal.pgen.1005413.
48. Rouch, D. A., Messerotti, L. J., Loo, L. S., Jackson, C. A., and Skurray, R. A. (1989). Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257. Mol. Microbiol. 3, 161-175. doi: 10.1111/j.1365-2958.1989.tb01805.x.
49. Schoenfelder, S. M., Lange, C., Eckart, M., Hennig, S., Kozytska, S., and Ziebuhr, W. (2010). Success through diversity-how Staphylococcus epidermidis establishes as a nosocomial pathogen. Int. J. Med. Microbiol. 300, 380-386. doi: 10.1016/j.ijmm.2010.04.011.
50. Schweizer, H. P. (2001). Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol. Lett. 202, 1-7. doi: 10.1111/j.1574-6968.2001.tb10772.x.
51. Siguier, P., Gourbeyre, E., and Chandler, M. (2014). Bacterial insertion sequences: their genomic impact and diversity. FEMS Microbiol. Rev. 38, 865-891. doi: 10.1111/1574-6976.12067.
52. Siguier, P., Gourbeyre, E., Varani, A., Ton-Hoang, B., and Chandler, M. (2015). Everyman's guide to bacterial insertion sequences. Microbiol. Spectr. 3:MDNA3-0030-2014 doi: 10.1128/microbiolspec.mdna3-0030-2014.
53. Slater-Radosti, C., Van Aller, G., Greenwood, R., Nicholas, R., Keller, P. M., DeWolf, W. E. Jr., et al. (2001). Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J. Antimicrob. Chemother. 48, 1-6. doi: 10.1093/jac/48.1.1.
54. Tonouchi, N., Tsuchida, T., Yoshinaga, F., Horinouchi, S., and Beppu, T. (1994). A host-vector system for a cellulose-producing Acetobacter strain. Biosci. Biotechnol. Biochem. 58, 1899-1901. doi: 10.1271/bbb.58.1899.
55. Woodford, N., Watson, A. P., Patel, S., Jevon, M., Waghorn, D. J., and Cookson, B. D. (1998). Heterogeneous location of the mupA high-level mupirocin resistance gene in Staphylococcus aureus. J. Med. Microbiol. 47, 829-835. doi: 10.1099/00222615-47-9-829.
56. Yesilkaya, H., Meacci, F., Niemann, S., Hillemann, D., Rusch-Gerdes, S., Group, L. D. S., et al. (2006). Evaluation of molecular-Beacon, TaqMan, and fluorescence resonance energy transfer probes for detection of antibiotic resistance-conferring single nucleotide polymorphisms in mixed Mycobacterium tuberculosis DNA extracts. J. Clin. Microbiol. 44, 3826-3829. doi: 10.1128/JCM.00225-06.
57. Zhang, Y. Q., Ren, S. X., Li, H. L., Wang, Y. X., Fu, G., Yang, J., et al. (2003). Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol. Microbiol. 49, 1577-1593. doi: 10.1046/j.1365-2958.2003.03671.x.